13F HOLDINGS REPORT
Octagon Capital Advisors LP
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001839435-24-000005
Total Value
$636.3M
Positions
47
Other Managers
0
Confidential Omitted
No
Holdings (47)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | APELLIS PHARMACEUTICALS INC | APLS | 2,880,880 | $110.5M | 17.37% |
| 2 | DIANTHUS THERAPEUTICS INC | DNTH | 1,746,667 | $45.2M | 7.10% |
| 3 | STRUCTURE THERAPEUTICS INC | GPCR | 1,140,060 | $44.8M | 7.04% |
| 4 | INSMED INC | INSM | 650,216 | $43.6M | 6.85% |
| 5 | DYNE THERAPEUTICS INC | DYN | 1,180,798 | $41.7M | 6.55% |
| 6 | ARRIVENT BIOPHARMA INC | AVBP | 1,803,304 | $33.5M | 5.26% |
| 7 | VERONA PHARMA PLC | 925050106 | 1,895,200 | $27.4M | 4.31% |
| 8 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 488,000 | $22.1M | 3.47% |
| 9 | CENTESSA PHARMACEUTICALS PLC | CNTA | 2,345,075 | $21.2M | 3.33% |
| 10 | BRIDGEBIO PHARMA INC | BBIO | 690,000 | $17.5M | 2.75% |
| 11 | INSMED INC | INSM | 250,000 | $16.8M | 2.63% |
| 12 | OCULAR THERAPEUTIX INC | OCUL | 2,425,000 | $16.6M | 2.61% |
| 13 | PERSPECTIVE THERAPEUTICS INC | CATX | 1,580,249 | $15.8M | 2.48% |
| 14 | MIND MEDICINE MINDMED INC | 60255C885 | 2,153,000 | $15.5M | 2.44% |
| 15 | PRAXIS PRECISION MEDICINES I | PRAX | 260,000 | $10.8M | 1.69% |
| 16 | TAYSHA GENE THERAPIES INC | TSHA | 4,572,222 | $10.2M | 1.61% |
| 17 | EYEPOINT PHARMACEUTICALS INC | EYPT | 1,093,503 | $9.5M | 1.50% |
| 18 | TERNS PHARMACEUTICALS INC | TERN | 1,364,400 | $9.3M | 1.46% |
| 19 | GOSSAMER BIO INC | GOSS | 9,187,883 | $8.3M | 1.30% |
| 20 | VIRIDIAN THERAPEUTICS INC | VRDN | 620,000 | $8.1M | 1.27% |
| 21 | TENAYA THERAPEUTICS INC | TNYA | 2,576,200 | $8.0M | 1.26% |
| 22 | APELLIS PHARMACEUTICALS INC | APLS | 200,000 | $7.7M | 1.21% |
| 23 | REGULUS THERAPEUTICS INC | 75915K309 | 4,263,701 | $7.6M | 1.20% |
| 24 | ALLOVIR INC | 019818103 | 9,800,000 | $7.1M | 1.11% |
| 25 | MINERALYS THERAPEUTICS INC | MLYS | 600,000 | $7.0M | 1.10% |
| 26 | AN2 THERAPEUTICS INC | ANTX | 3,220,263 | $6.9M | 1.09% |
| 27 | AKERO THERAPEUTICS INC | 00973Y108 | 283,372 | $6.6M | 1.04% |
| 28 | JASPER THERAPEUTICS INC | JSPRW | 287,500 | $6.5M | 1.03% |
| 29 | PEPGEN INC | PEPG | 376,117 | $6.0M | 0.94% |
| 30 | APELLIS PHARMACEUTICALS INC | APLS | 150,000 | $5.8M | 0.90% |
| 31 | VENTYX BIOSCIENCES INC | 92332V107 | 2,391,114 | $5.5M | 0.87% |
| 32 | CYBIN INC | HELP | 18,604,650 | $5.0M | 0.79% |
| 33 | CENTURY THERAPEUTICS INC | IPSC | 1,333,650 | $3.4M | 0.53% |
| 34 | RENEO PHARMACEUTICALS INC | 75974E103 | 2,250,000 | $3.4M | 0.53% |
| 35 | SILENCE THERAPEUTICS PLC | SLNCF | 176,000 | $3.3M | 0.53% |
| 36 | HELIX ACQUISITION CORP II | HLXC | 250,000 | $2.6M | 0.40% |
| 37 | POSEIDA THERAPEUTICS INC | 73730P108 | 736,000 | $2.1M | 0.34% |
| 38 | ELEVATION ONCOLOGY INC | 28623U101 | 747,000 | $2.0M | 0.32% |
| 39 | MERSANA THERAPEUTICS INC | 59045L106 | 992,000 | $2.0M | 0.31% |
| 40 | ANNEXON INC | ANNX | 400,000 | $2.0M | 0.31% |
| 41 | FATE THERAPEUTICS INC | FATE | 520,800 | $1.7M | 0.27% |
| 42 | NKARTA INC | NKTX | 240,000 | $1.4M | 0.22% |
| 43 | NUVATION BIO INC | NUVB | 431,600 | $1.3M | 0.20% |
| 44 | ADICET BIO INC | ACET | 767,799 | $929,037 | 0.15% |
| 45 | RAPT THERAPEUTICS INC | 75382E109 | 292,000 | $890,600 | 0.14% |
| 46 | AEROVATE THERAPEUTICS INC | 008064107 | 465,440 | $772,630 | 0.12% |
| 47 | AUTOLUS THERAPEUTICS PLC | AUTL | 176,000 | $612,480 | 0.10% |